Joel Greenblatt acquired 32.9k Veracyte shares worth $1.07M. That's 0.01% of their equity portfolio (1109th largest holding). The first Veracyte trade was made in Q2 2019. Since then Joel Greenblatt bought shares nine more times and sold shares on nine occasions. The stake costed the investor $791k, netting the investor a gain of 35% so far.